Trial record 1 of 1 for:
CR845-310301
A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05342623 |
Recruitment Status :
Terminated
(Corporate decision to discontinue work in advanced chronic kidney disease.)
First Posted : April 22, 2022
Last Update Posted : May 7, 2024
|
Sponsor:
Cara Therapeutics, Inc.
Information provided by (Responsible Party):
Cara Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | February 29, 2024 |
Actual Study Completion Date : | February 29, 2024 |